Canada’s plant health surveillance infrastructure is getting a major technology upgrade. The Canadian Food Inspection Agency (CFIA) has announced plans to implement high-throughput sequencing (HTS) at the Centre for Plant Health as part of their 2026-2027 departmental strategy. This move signals a fundamental shift in how Canada detects, identifies, and responds to plant pests and pathogens, and it has significant implications for growers, nurseries, and importers across the country.
What Is High-Throughput Sequencing?
High-throughput sequencing, also known as next-generation sequencing (NGS), is a technology that reads millions of DNA or RNA fragments simultaneously. In the context of plant health, this means a single test can detect virtually every pathogen present in a sample, including viruses, bacteria, fungi, and viroids, without needing to know in advance what you are looking for.
This is a transformative capability. Traditional diagnostic methods, including ELISA, PCR, and immunoassay strips, are targeted tests. You need to suspect a specific pathogen and then test for it. If you do not suspect it, you do not test for it, and you do not find it. The 20-year silent spread of Cotton Leafroll Dwarf Virus in the United States is a perfect example of what happens when targeted testing misses a pathogen that nobody is looking for.
HTS flips this paradigm. Instead of asking “Is pathogen X present?”, it asks “What is present?” This untargeted approach is particularly valuable for detecting novel pathogens, identifying co-infections that traditional tests might miss, and catching emerging threats before they establish widespread populations.
Why the CFIA Is Investing Now
Several converging factors make this the right time for Canada to invest in HTS-based plant health surveillance. Global trade volumes continue to increase, bringing new pest and disease risks with every shipment of plant material. Climate change is expanding the geographic range of both pests and pathogens, with invasive species like the spotted lanternfly already present in 19 U.S. states and the District of Columbia. And recent experience with viruses like Tomato Brown Rugose Fruit Virus (ToBRFV) has demonstrated how quickly a new pathogen can spread through global supply chains.
The CFIA’s 2026-2027 departmental plan identifies several priority pest threats, including spotted lanternfly, oak wilt, emerald ash borer, Japanese stiltgrass, Japanese beetle, plum pox virus, and hemlock woolly adelgid. HTS technology will enhance the agency’s ability to detect these known threats while also providing the capability to identify completely new ones.
What This Means for Growers and Nurseries
For Canadian growers, nurseries, and greenhouse operators, the CFIA’s adoption of HTS technology has several practical implications. First, expect enhanced surveillance of imported plant material. HTS screening at ports of entry and inspection facilities will likely catch more regulated pests, potentially leading to more interceptions and rejections of contaminated shipments.
Second, the technology may eventually become available for routine diagnostic submissions. If you send a symptomatic plant sample to a CFIA-affiliated diagnostic laboratory, HTS analysis could identify multiple pathogens simultaneously, giving you a much more complete picture of what is affecting your crop.
Third, the data generated by HTS surveillance will improve risk assessments and pest forecasting. Better knowledge of what pathogens are present and where they are distributed leads to more targeted and effective management recommendations.
How HTS Complements Existing Diagnostic Tools
It is important to understand that HTS does not replace existing diagnostic methods. Rather, it adds a powerful new layer to the diagnostic toolkit. Rapid field-side tests like ImmunoStrips for ToBRFV and other pathogens remain essential for quick, on-the-spot decisions. ELISA-based testing provides reliable, quantitative results for known target pathogens. And isothermal amplification technologies like AmplifyRP offer sensitive molecular detection without the infrastructure requirements of a full sequencing laboratory.
The strength of HTS is in its role as a discovery and surveillance tool. When a new symptom appears that does not match known diseases, when imports from a new source region need comprehensive screening, or when a comprehensive baseline survey of pathogen diversity is needed, HTS is the technology of choice. The results from HTS analysis can then inform which targeted diagnostic tests to deploy for ongoing monitoring.
The Broader Trend Toward Genomic Surveillance
Canada is not alone in adopting genomic approaches to plant health. The European Union, Australia, and New Zealand have all invested heavily in HTS-based phytosanitary surveillance in recent years. The United States Department of Agriculture (USDA) has used metagenomics approaches to retroactively identify pathogens in archived samples, as demonstrated by the recent CLRDV discovery.
This global trend reflects a recognition that the traditional model of plant disease diagnosis, relying primarily on visual symptoms and targeted laboratory tests, is insufficient for the complexity and speed of modern pest and disease threats. Genomic surveillance provides the early warning capability that national plant health systems need to stay ahead of emerging risks.
Preparing for the Future
For forward-thinking operations, the CFIA’s HTS investment is a signal to start thinking about how genomic diagnostics might integrate into your own quality management system. While HTS itself requires significant laboratory infrastructure, the downstream benefits, including better pest identification, more targeted management, and faster regulatory response, will flow through to growers and the supply chain.
In the meantime, building a robust on-site testing capability using proven rapid and laboratory diagnostic technologies ensures you can catch known threats quickly while the national surveillance infrastructure catches the unknown ones. A layered approach combining field-side rapid tests, laboratory ELISA and molecular methods, and access to advanced genomic diagnostics through the CFIA creates the most comprehensive plant health protection available to Canadian growers today.
